Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw

Australian Dental Journal

Volumn 57, Issue 2, 2012, Pages 227-230

  Hewson, I ^a   Syme, D ^a   Bruscino Raiola, F ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Bisphosphonates; osteonecrosis of the jaws; surgery

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; IMIDAZOLE DERIVATIVE; PAMIDRONIC ACID; PEPTIDE; ZOLEDRONIC ACID;

ARTICLE; BLOOD; CASE REPORT; FEMALE; HUMAN; JAW DISEASE; JAW OSTEONECROSIS; MAXILLA OSTEOTOMY; METHODOLOGY; MIDDLE AGED; MULTIPLE MYELOMA; SURGICAL FLAPS; TOOTH EXTRACTION;

BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; COLLAGEN TYPE I; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; MAXILLARY DISEASES; MAXILLARY OSTEOTOMY; MIDDLE AGED; MULTIPLE MYELOMA; PEPTIDES; SURGICAL FLAPS; TOOTH EXTRACTION;

EID: 84861631720     PISSN: 00450421     EISSN: 18347819     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2012.01675.x     Document Type: Article

References (18)

1. Smith A, Wisloff F, Samson D,. Guidelines for the diagnosis and management of multiple myeloma. Br J Haematol 2006; 132: 410-451.
2. Wang J, Goodger NM, Pogrel MA,. Osteonecrosis of the jaws associated with cancer therapy. J Oral Maxillofac Surg 2003; 61: 1104-1107.
3. Marx RE,. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-1117.
4. Migliorati CA,. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003; 21: 4253-4254.
5. Cheng A, Mavrokokki A, Carter G,. The dental implications of bisphosphonates and bone disease. Aust Dent J 2005; 4 (Suppl 2): S4-13.
6. Migliorati CA, Siegel MA, Elting LS,. Bisphosphonate associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 2006; 7: 508-514. Erratum in: Lancet Oncol 2006; 7:533.
7. Migliorati CA, Woo SB, Hewson I, et al., A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer 2010; 18: 1099-1106.
8. Bamias A, Kastritis E, Bamia C, et al., Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005; 23: 8580-8587.
9. Mavrokokki T, Cheng A, Stein B, Goss A,. Nature and frequency of bisphosphonate associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007; 65: 415-423.
10. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB,. Managing the care of patients with bisphosphonate associated osteonecrosis. American Academy of Oral Medicine position paper. J Am Dent Assoc 2005; 136: 1658-1668.
11. Freiberger JJ, Padilla-Burgos R, Chhoeu AH, et al., Hyperbaric oxygen treatment and bisphosphonate induced osteonecrosis of the jaw: a case series. J Oral Maxillofac Surg 2007; 65: 1321-1327.
12. Ruggiero SL, Fantasia J, Carlson E,. Bisphosphonate related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 433-441.
13. Cheng A, Daly CG, Logan RM, Stein B, Goss AN,. Alveolar bone and the bisphosphonates. Aust Dent J 2009; 54 (1 Suppl): S51-61.
14. Marx R,. Oral and intravenous bisphosphonate induced osteonecrosis of the jaws. Quintessence Publishing, 2007.
15. Kunchur R, Need A, Hughes T, Goss A,. Clinical investigation of C-terminal cross-linked telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 2009; 67: 1167-1173.
16. Dickinson M, Prince HM, Kirsa S, et al., Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Intern Med J 2009; 39: 304-316.
17. Stockmann P, Vairaktaris E, Wehrhan F, et al., Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 month follow-up. Support Care Cancer 2010; 18: 449-460.
18. Williamson RA,. Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 2010; 39: 251-255.